跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
EPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle
Approved
STANDARD
EPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle
Gilead Sciences Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
bf21ba9c44dd3c57
Company
Gilead Sciences Pty Ltd
Type
Standard
Approval Details
Approval Id
bf21ba9c44dd3c57
Product Name
EPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle
Artg Id
266823
Artg Name
EPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle
Sponsor
Gilead Sciences Pty Ltd
Company Detail Path
/organization/gilead-sciences-pty-limited
Artg Date
2016-12-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/1191d0028a5603c6e7d50a783240df39.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/007a96cae74fa39eb6e64b7cfe00ee48.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
bf21ba9c44dd3c57
Type
Standard
Back to TGA Approvals
EPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle - TGA Drug Approval Details
